Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk

Risk of epithelial ovarian cancer (EOC) attendant to use of hormone replacement therapy (HRT) was evaluated in a population-based case–control study of newly diagnosed EOC cases ( n = 256) and randomly selected population controls ( n = 1122). Telephone interviews were conducted to obtain informatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer detection and prevention 2005-01, Vol.29 (2), p.124-132
Hauptverfasser: Mills, Paul K., Riordan, Deborah G., Cress, Rosemary D., Goldsmith, David F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!